Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 03, 2021
Grace has entered into a definitive agreement to acquire the Fine Chemistry Services business of Albemarle for approximately $570 million.
read more
The FDA issued an EUA for the third vaccine for the prevention of COVID-19.
read more
Monday, February 22, 2021
Wavelength Pharmaceuticals announced the acquisition of a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India.
read more
Monday, February 22, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs under cGMP.
read more
Thursday, February 18, 2021
ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
Thursday, February 18, 2021
SCYNEXIS has entered into a licensing agreement and strategic partnership with Hansoh Pharmaceutical Group.
read more
Friday, February 12, 2021
AzurRx BioPharma has entered into an agreement with PPD for its trial evaluating micronized niclosamide for COVID-19-associated GI infections.
read more
Wednesday, February 10, 2021
Longevity Acquisition and 4D pharma have announced a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for BAVENCIO.
read more
Monday, February 01, 2021
RedHill Biopharma announced a manufacturing agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for opaganib.
read more
Relief and Acer announced the companies have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license agreement for worldwide development and commercialization for ACER-001.
read more
Civica Rx has announced plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
read more
Akston Biosciences and LakePharma have established a strategic partnership.
read more
Precision Dose is voluntarily recalling all lots of Chlorhexidine Gluconate Oral Rinse USP, 0.12%, 15mL Unit Dose Cups to the consumer level.
read more
Wednesday, January 06, 2021
Aurobindo Pharma and COVAXX have entered into an agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and UNICEF.
read more
Wednesday, January 06, 2021
Panthera’s clinical trial sites began dosing volunteers in the Phase III trial which will evaluate AstraZeneca’s long-acting antibody combination for the potential prevention of COVID-19.
read more